Trial Profile
OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 04 Mar 2020
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Cisplatin; Doxorubicin; Etoposide; Ifosfamide; Methotrexate
- Indications Osteosarcoma
- Focus Registrational; Therapeutic Use
- Acronyms OS 2006
- 15 Jan 2020 Results (n=106) of subgroup analysis of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study has been published in the International Journal of Cancer
- 17 Oct 2019 Planned End Date changed from 1 Apr 2025 to 1 Dec 2025.
- 04 Jan 2016 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.